Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial
- 15 August 1991
- Vol. 68 (4) , 744-746
- https://doi.org/10.1002/1097-0142(19910815)68:4<744::aid-cncr2820680414>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 5-Fluorouracil With Oral Leucovorin and Hydroxyurea and Concomitant Radiotherapy for Stage III Non-Small Cell Lung CancerCancer, 1990
- Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.Journal of Clinical Oncology, 1989
- A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulationCancer, 1989
- A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancerCancer Chemotherapy and Pharmacology, 1985
- Sequential methotrexate and 5-fluorouracil in the primary treatment of metastatic colorectal carcinomaAmerican Journal of Clinical Oncology, 1985
- Chemotherapy of advanced colorectal carcinomaAmerican Journal of Clinical Oncology, 1984
- Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.Journal of Clinical Oncology, 1984